MARKSANS PHARMA Q3 FY25 Results

MARKSANS PHARMA has released its financial results for the Q3 quarter of Financial Year 24-2025. Here's a comprehensive breakdown of the company's performance:

Revenue Analysis

• Current Quarter Revenue: Rs. 681.85 Cr
• Quarter-on-Quarter (QoQ) Change: 6.22% (Previous Quarter: Rs. 641.92 Cr )
• Year-on-Year (YoY) Change: 16.33% (Same Quarter Last Year: Rs. 586.13 Cr )

Profitability Metrics

• Net Profit: Rs. 105.07 Cr
• QoQ Profit Change: 7.47% (Previous Quarter: Rs. 97.76 Cr )
• YoY Profit Change: 26.64% (Same Quarter Last Year: Rs. 82.97 Cr )

Shareholder Returns

• Earnings Per Share (EPS): Rs. 2.31
• QoQ EPS Change: 8.45% (Previous Quarter: Rs. 2.13)
• YoY EPS Change: 25.54% (Same Quarter Last Year: Rs. 1.84)

Performance Summary

Strong

MARKSANS PHARMA increased profits more than sales, showing they're managing costs well.

This analysis provides a snapshot of MARKSANS PHARMA's financial performance. Investors and analysts should consider these results in the context of broader market trends and the company's long-term strategy.